3Dnamics Inc.
Doing business as 3Dnamics Inc. 3Dnamics, Inc.
- UEI
- CLTRL7999LU8
- CAGE
- 80D00
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- 3dnamics.com
- Founded
- 2016
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Ipsc-derived hepatocyte organoids - liver organoids these liver organoids will be used to develop high-throughput assays… | National Institute on Drug Abuse | $24,750 | |
| Generation of brain organoids to study sars-COV-2 neurotropism (covid-19 action) | National Institute on Drug Abuse | $20,000 | |
| Phenotypic CO-culture assay for alagille syndrome project | National Institute on Drug Abuse | $50,000 | |
| Lab testing service generation of 90-day midbrain organoids for RNA and protein work | National Center for Advancing Translational Sciences | $24,000 | |
| Evaluation of mature and functional hepatocyte organoids derived from induced pluripotent stem cell | National Institute on Drug Abuse | $40,000 |
About 3Dnamics Inc.
3Dnamics Inc. is a biotechnology company that provides stem cell engineering technology and related services. They strive to improve human health through innovative applications of this technology. 3Dnamics Inc. has received several federal contract awards to provide biotechnology research and testing services related to stem cell applications.
Specific services provided by 3Dnamics Inc. under federal contracts include generating organoids from induced pluripotent stem cells for disease modeling and drug toxicity testing, funded by NIH's National Institute on Drug Abuse and National Center for Advancing Translational Sciences. They have also produced brain organoids to study SARS-CoV-2 neurotropism under a COVID-19 research contract from NIH. Additional services include stem cell differentiation and characterization, phenotypic assay development, and general stem cell engineering research to model liver disease, funded by multiple NIH institutes. All of these federal awards have gone directly to 3Dnamics Inc. as the prime contractor. To date, none of 3Dnamics Inc.'s federal awards have utilized small business set asides.
Quick answers
What is 3Dnamics Inc.'s UEI?
3Dnamics Inc.'s Unique Entity ID (UEI) in SAM.gov is CLTRL7999LU8.
What is 3Dnamics Inc.'s CAGE code?
3Dnamics Inc.'s CAGE code is 80D00.
What is 3Dnamics Inc.'s primary NAICS code?
3Dnamics Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Is 3Dnamics Inc. registered in SAM.gov?
3Dnamics Inc.'s SAM.gov registration expired on May 9, 2024.
What is 3Dnamics Inc.'s most recent federal award?
3Dnamics Inc.'s most recent federal contract award is Ipsc-derived hepatocyte organoids - liver organoids these liver organoids will be used to develop high-throughput assays… (75N95022P00672), from National Institute on Drug Abuse, on September 21, 2022.
On GovTribe
See 3Dnamics Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors